Venous XXXX events are rare after shoulder surgery: analysis of a national database.

@entity1 @entity174 @entity1151 @entity1150 @entity1031 @entity1211
BACKGROUND: Data on @entity1211 ( @entity1211 ) events after different types of shoulder surgery have not previously been available in large numbers in the United Kingdom. We aimed to determine baseline postoperative complication rates with reference to national @entity1031 prophylaxis guidelines. METHODS: Diagnostic and operative codes are routinely collected on every @entity1 admitted to the hospital in the English NHS. Data for a 42-month period were analyzed for planned shoulder surgery (total replacement, hemiarthroplasty, or arthroscopy) and proximal humeral @entity174 surgery (internal fixation or replacement). In addition, complications during the two 6-month periods before and after the implementation of national thromboprophylaxis guidelines were compared. Rates of symptomatic @entity1150 , @entity1151 , and mortality within 90 days were extracted. RESULTS: For total shoulder replacement (4,061 @entity1 ), @entity1150 , @entity1151 , and mortality rates were 0%, 0.20%, and 0.22%, respectively. For arthroscopic procedures (65,302 @entity1 ), the rates were less than 0.01%, 0.01%, and 0.03%, respectively. For proximal humeral @entity174 surgery (internal fixation or replacement, 4,696 @entity1 ), the rates were 0.19%, 0.40%, and 3.02%, respectively. There was no significant difference in the @entity1211 event or mortality rates before and after the introduction of the 2007 National Institute for Health and Clinical Excellence guidelines after arthroscopy or proximal humeral @entity174 surgery. A statistically significant decrease in total shoulder replacement-related mortality was found, from 0.72% (5 @entity1 ) to 0%. DISCUSSION: @entity1211 disease is not a significant problem after shoulder surgery, and thromboprophylaxis may not be required, even in high-risk @entity1 . National thromboprophylaxis guidelines did not affect @entity1211 event rates.
